XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock-Based Compensation Expense

Total stock-based compensation expense recognized in the Company’s consolidated statements of operations and comprehensive loss is classified as follows (in thousands):

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Cost of revenue

 

$

236

 

 

$

238

 

Research and development

 

 

637

 

 

 

520

 

Selling and marketing

 

 

295

 

 

 

216

 

General and administrative

 

 

7,326

 

 

 

4,527

 

Total stock-based compensation expense

 

$

8,494

 

 

$

5,501

 

Summary of RSU Activity

A summary of the Company’s RSU activity and related information is as follows:

 

 

 

RSUs

 

 

 

Number of Shares

 

 

Weighted Average Grant Date Fair Value

 

Unvested at December 31, 2020

 

 

8,046,399

 

 

$

3.41

 

RSUs granted

 

 

2,890,478

 

 

 

4.67

 

RSUs vested

 

 

(1,556,823

)

 

 

3.54

 

RSUs forfeited

 

 

(162,558

)

 

 

3.66

 

Unvested at March 31, 2021

 

 

9,217,496

 

 

$

3.79

 

Vested and unreleased

 

 

177,644

 

 

 

 

 

Outstanding at March 31, 2021

 

 

9,395,140

 

 

 

 

 

Summary of Company's Stock Option Activity and Related Information

A summary of the Company’s stock option activity and related information is as follows:

 

 

Number

of Stock

Options

Outstanding

 

 

Weighted-Average Exercise Price

 

 

Weighted-

Average

Remaining

Contractual Life

(Years)

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands)

 

Options outstanding at December 31, 2020

 

 

8,142,348

 

 

$

7.14

 

 

 

7.3

 

 

$

2,638

 

Options granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(6,021

)

 

 

3.10

 

 

 

 

 

 

 

 

 

Options cancelled or forfeited

 

 

(39,422

)

 

 

6.58

 

 

 

 

 

 

 

 

 

Options outstanding at March 31, 2021

 

 

8,096,905

 

 

$

7.15

 

 

 

6.9

 

 

$

3,309

 

Options exercisable at March 31, 2021

 

 

5,676,389

 

 

$

7.24

 

 

 

6.4

 

 

$

1,755

 

Options vested and expected to vest at March 31, 2021

 

 

7,889,379

 

 

$

7.18

 

 

 

6.9

 

 

$

3,101

 

Schedule of Weighted-Average Assumptions Used in Black-Scholes Option-Pricing Model to Estimate Fair Value of Employee Stock Options at Grant Date

The fair value of employee stock options was estimated at the date of grant using a Black-Scholes option-pricing model with the following weighted-average assumptions:

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

Expected term (in years)

 

 

6.1

 

Expected volatility

 

66.5%

 

Risk-free interest rate

 

1.4%

 

Expected dividend yield

 

0.0%